Businessfrom24/7 Wall St.4 days agoDanaher's $9.9B Masimo Deal Marks One of 2026's Largest Medtech BuyoutsDanaher will acquire Masimo for $9.9 billion in cash at $180 per share, about a 40% premium; closing expected in second half of 2026.